SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001655759-22-000018
Filing Date
2022-06-09
Accepted
2022-06-09 16:34:21
Documents
12
Period of Report
2022-06-04
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K arvn-20220604.htm   iXBRL 8-K 39021
  Complete submission text file 0001655759-22-000018.txt   180767

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT arvn-20220604.xsd EX-101.SCH 1899
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT arvn-20220604_lab.xml EX-101.LAB 24849
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT arvn-20220604_pre.xml EX-101.PRE 13044
6 EXTRACTED XBRL INSTANCE DOCUMENT arvn-20220604_htm.xml XML 11886
Mailing Address 395 WINCHESTER AVE 5 SCIENCE PARK NEW HAVEN CT 06511
Business Address 395 WINCHESTER AVE 5 SCIENCE PARK NEW HAVEN CT 06511 203-535-1456
ARVINAS, INC. (Filer) CIK: 0001655759 (see all company filings)

IRS No.: 472566120 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38672 | Film No.: 221006394
SIC: 2834 Pharmaceutical Preparations